SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-733802
Filing Date
2016-10-07
Accepted
2016-10-07 16:05:02
Documents
7
Period of Report
2016-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d244810d8k.htm 8-K 21036
2 EX-1.1 d244810dex11.htm EX-1.1 213025
3 EX-5.1 d244810dex51.htm EX-5.1 8176
4 EX-99.1 d244810dex991.htm EX-99.1 8767
5 EX-99.2 d244810dex992.htm EX-99.2 8301
6 GRAPHIC g244810snap1.jpg GRAPHIC 11272
7 GRAPHIC g244810snap2.jpg GRAPHIC 7987
  Complete submission text file 0001193125-16-733802.txt   287420
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 161928051
SIC: 2836 Biological Products, (No Diagnostic Substances)